Zidovudine and Lamivudine Tablets Manufacturer in India | Sunrise Remedies 

Zidovudine and Lamivudine Tablets are combination antiretroviral medicines used as part of HIV treatment. The combination contains two nucleoside reverse transcriptase inhibitors (NRTIs), Zidovudine and Lamivudine, which work together to reduce HIV replication. Combination therapy is generally selected and monitored by qualified healthcare professionals according to the patient's treatment plan, medical history, laboratory results, and applicable treatment guidelines.

Sunrise Remedies is engaged in the pharmaceutical sector and offers its product Zidosun-L for pharmaceutical supply. The company focuses on providing pharmaceutical products for healthcare markets and supports business requirements through organized product handling and supply services.

What Are Zidovudine and Lamivudine Tablets?

Zidovudine and Lamivudine Tablets contain two antiretroviral active ingredients. Zidovudine interferes with HIV reverse transcriptase, an enzyme required by the virus to produce its genetic material. Lamivudine works through a similar mechanism. By inhibiting this viral process, these medicines can help reduce the amount of HIV in the body when used as part of an appropriate antiretroviral regimen.

The combination is not intended to be used without medical supervision. HIV treatment usually involves a complete antiretroviral regimen selected by a healthcare professional. Patients should follow the prescribed treatment schedule and should not change or discontinue medicines without consulting their healthcare provider.

Zidosun-L by Sunrise Remedies

Zidosun-L is the brand associated with Sunrise Remedies for its Zidovudine and Lamivudine combination product. It is intended for pharmaceutical distribution and supply requirements where this combination is included in an appropriate HIV treatment program.

For healthcare professionals, distributors, institutions, and pharmaceutical procurement teams, product information such as composition, strength, packaging, availability, regulatory documentation, and supply requirements should be confirmed directly with the manufacturer or authorized supplier before placing an order.

How Do Zidovudine and Lamivudine Work?

Both Zidovudine and Lamivudine belong to the NRTI class of antiretroviral medicines. HIV uses reverse transcriptase to convert its RNA into DNA, which is an important stage in the viral replication cycle.

Zidovudine and Lamivudine are converted inside cells into active forms that interfere with the viral reverse transcriptase process. This helps prevent the virus from producing new genetic material efficiently.

When used correctly as part of combination antiretroviral therapy, treatment can suppress HIV replication. Consistent adherence is important because missed doses can reduce treatment effectiveness and may contribute to the development of drug resistance.

Uses of Zidovudine and Lamivudine Tablets

Zidovudine and Lamivudine Tablets may be prescribed as part of an antiretroviral treatment regimen for people living with HIV. The exact place of this combination in treatment depends on current clinical guidelines, previous treatment history, resistance considerations, other medicines, and individual patient factors.

Potential treatment objectives include:

• Helping suppress HIV replication

• Supporting maintenance of viral suppression

• Reducing the amount of HIV in the bloodstream when used appropriately

• Supporting the long-term management of HIV infection

• Forming part of combination antiretroviral therapy when clinically indicated

These tablets should only be used according to the instructions of a qualified healthcare professional.

Importance of Proper Treatment Adherence

Adherence plays an important role in HIV treatment. Antiretroviral medicines work best when taken according to the prescribed schedule. Missing doses repeatedly may allow HIV to multiply and can increase the risk of resistance to medicines.

Patients should take their medication exactly as prescribed. If a dose is missed, they should follow the instructions provided by their healthcare professional or the product information rather than independently taking extra doses.

Regular medical follow-up is also important. Healthcare providers may monitor viral load, immune status, blood counts, liver and kidney function, and other relevant parameters depending on the treatment plan.

Possible Side Effects and Safety Considerations

Like other medicines, Zidovudine and Lamivudine Tablets can cause side effects. The nature and severity of side effects can vary between individuals.

Zidovudine is associated with important hematological effects, including anemia and neutropenia, particularly in certain patients or with prolonged use. Other possible adverse effects may include headache, nausea, fatigue, gastrointestinal symptoms, or muscle-related symptoms.

Lamivudine is generally well tolerated by many patients, but adverse effects can occur. Patients should discuss unusual or persistent symptoms with their healthcare provider.

People taking this combination may require appropriate clinical and laboratory monitoring. Any history of liver disease, kidney problems, blood disorders, or other significant medical conditions should be communicated to the healthcare professional before treatment.

Important Precautions

Zidovudine and Lamivudine Tablets should be used under professional medical guidance. Patients should inform their healthcare provider about all prescription medicines, over-the-counter products, supplements, and other treatments they are taking.

Special attention may be required in individuals with:

• Liver or kidney impairment

• Anemia or other blood disorders

• Previous antiretroviral treatment

• Possible drug resistance

• Other ongoing medical conditions

• Pregnancy or breastfeeding

The healthcare provider can determine whether this combination is appropriate and whether additional monitoring is required.

Why Pharmaceutical Product Quality Matters

For antiretroviral medicines, appropriate manufacturing, quality control, packaging, storage, and distribution practices are important considerations. Pharmaceutical products should be sourced through appropriate channels and handled according to applicable storage and regulatory requirements.

Manufacturers and suppliers serving healthcare markets should maintain suitable quality systems and provide relevant product documentation where applicable. Procurement teams should verify product specifications, regulatory status, packaging details, batch information, and supply terms before purchasing.

Pharmaceutical Supply from Sunrise Remedies

Sunrise Remedies provides pharmaceutical products for healthcare and business requirements. Its product portfolio includes Zidosun-L, associated with the Zidovudine and Lamivudine combination.

Businesses interested in pharmaceutical sourcing can contact Sunrise Remedies to discuss product specifications, packaging requirements, availability, and commercial supply opportunities. Product availability and applicable distribution conditions may vary according to market and regulatory requirements.

Who Can Contact Sunrise Remedies?

The product may be relevant to pharmaceutical distributors, wholesalers, healthcare procurement organizations, institutional buyers, and other authorized pharmaceutical businesses seeking information about Zidovudine and Lamivudine combination products.

Before purchasing or distributing pharmaceutical products, buyers should ensure that all applicable local regulatory, licensing, import, export, storage, and distribution requirements are met.

Frequently Asked Questions

1. What are Zidovudine and Lamivudine Tablets used for?
   They are antiretroviral medicines used as part of combination therapy for HIV infection. Their use should be determined by a qualified healthcare professional.

2. What is the brand name of the product from Sunrise Remedies?
   The product brand name provided by Sunrise Remedies is Zidosun-L.

3. Can Zidovudine and Lamivudine Tablets be taken without a prescription?
   Antiretroviral treatment should be taken under the supervision of a qualified healthcare professional. Patients should not start, stop, or modify HIV treatment independently.

4. Is adherence important during HIV treatment?
   Yes. Taking antiretroviral medicines according to the prescribed schedule is important for maintaining effective viral suppression and reducing the risk of treatment resistance.

5. Where can I get product information for Zidosun-L?
   For information about Zidosun-L, including product specifications and pharmaceutical supply requirements, interested buyers can contact Sunrise Remedies directly.

Contact Sunrise Remedies

Sunrise Remedies aims to support pharmaceutical sourcing requirements with its range of healthcare products. For inquiries regarding Zidosun-L Or Zidovudine and Lamivudine Tablets, contact the company using the details below:

Phone: +91 7575043215

Email: info@sunriseremedies.in

Website: sunriseremedies.in

For product availability, specifications, packaging, and supply-related inquiries, contact Sunrise Remedies directly for the most current information.